nitroaspirin has been researched along with lipoxin a4 in 1 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (lipoxin a4) | Trials (lipoxin a4) | Recent Studies (post-2010) (lipoxin a4) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 833 | 17 | 398 |
| Protein | Taxonomy | nitroaspirin (IC50) | lipoxin a4 (IC50) |
|---|---|---|---|
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.0001 | |
| N-formyl peptide receptor 2 | Homo sapiens (human) | 0.0119 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.0001 | |
| Transcription factor p65 | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| del Soldato, P; Dicay, M; Fiorucci, S; McKnight, W; Mencarelli, A; Wallace, JL; Zamuner, SR | 1 |
1 other study(ies) available for nitroaspirin and lipoxin a4
| Article | Year |
|---|---|
Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Gastric Mucosa; Gastritis; Isoenzymes; Lipoxins; Male; Neutropenia; Neutrophil Infiltration; Nitric Oxide; Peroxidase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction | 2004 |